AYURF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Aug 11 closing price
Capitalization
3.54M
HLBBF
Price
$5.52
Change
+$0.37 (+7.18%)
Updated
Aug 12 closing price
Capitalization
5.86B
Interact to see
Advertisement

AYURF vs HLBBF

Header iconAYURF vs HLBBF Comparison
Open Charts AYURF vs HLBBFBanner chart's image
AYURCANN
Price$0.02
Change-$0.00 (-0.00%)
Volume$444
Capitalization3.54M
H. Lundbeck A/S
Price$5.52
Change+$0.37 (+7.18%)
Volume$1.7K
Capitalization5.86B
AYURF vs HLBBF Comparison Chart in %
Loading...
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYURF vs. HLBBF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYURF is a Hold and HLBBF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (AYURF: $0.02 vs. HLBBF: $5.52)
Brand notoriety: AYURF and HLBBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYURF: 1% vs. HLBBF: 484%
Market capitalization -- AYURF: $3.54M vs. HLBBF: $5.86B
AYURF [@Pharmaceuticals: Generic] is valued at $3.54M. HLBBF’s [@Pharmaceuticals: Generic] market capitalization is $5.86B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYURF’s FA Score shows that 0 FA rating(s) are green whileHLBBF’s FA Score has 1 green FA rating(s).

  • AYURF’s FA Score: 0 green, 5 red.
  • HLBBF’s FA Score: 1 green, 4 red.
According to our system of comparison, HLBBF is a better buy in the long-term than AYURF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYURF’s TA Score shows that 4 TA indicator(s) are bullish while HLBBF’s TA Score has 3 bullish TA indicator(s).

  • AYURF’s TA Score: 4 bullish, 4 bearish.
  • HLBBF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AYURF is a better buy in the short-term than HLBBF.

Price Growth

AYURF (@Pharmaceuticals: Generic) experienced а -0.56% price change this week, while HLBBF (@Pharmaceuticals: Generic) price change was +7.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLBBF($5.86B) has a higher market cap than AYURF($3.54M). AYURF YTD gains are higher at: 8.642 vs. HLBBF (-10.324). HLBBF has higher annual earnings (EBITDA): 4.25B vs. AYURF (-1.61M). HLBBF has more cash in the bank: 2.7B vs. AYURF (1.08M). AYURF has less debt than HLBBF: AYURF (2.74M) vs HLBBF (15.2B). HLBBF has higher revenues than AYURF: HLBBF (23B) vs AYURF (29.8M).
AYURFHLBBFAYURF / HLBBF
Capitalization3.54M5.86B0%
EBITDA-1.61M4.25B-0%
Gain YTD8.642-10.324-84%
P/E RatioN/A9.98-
Revenue29.8M23B0%
Total Cash1.08M2.7B0%
Total Debt2.74M15.2B0%
TECHNICAL ANALYSIS
Technical Analysis
AYURFHLBBF
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
45%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
52%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
32%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
38%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
46%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
36%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
AYURF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLBBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IOT33.531.31
+4.07%
Samsara
KROS14.480.06
+0.42%
Keros Therapeutics
TDW56.040.20
+0.36%
Tidewater
ELWS2.89-0.05
-1.70%
Earlyworks Co Ltd.
SAVA2.34-0.07
-2.90%
Cassava Sciences

AYURF and

Correlation & Price change

A.I.dvisor tells us that AYURF and PRFX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYURF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYURF
1D Price
Change %
AYURF100%
N/A
PRFX - AYURF
21%
Poorly correlated
-4.93%
HNSPF - AYURF
11%
Poorly correlated
N/A
STEK - AYURF
5%
Poorly correlated
+0.55%
BFRI - AYURF
3%
Poorly correlated
-3.73%
HLBBF - AYURF
-0%
Poorly correlated
N/A
More

HLBBF and

Correlation & Price change

A.I.dvisor tells us that HLBBF and HYEX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLBBF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
HYEX - HLBBF
21%
Poorly correlated
N/A
HLUBF - HLBBF
18%
Poorly correlated
N/A
HLN - HLBBF
10%
Poorly correlated
+0.09%
HLNCF - HLBBF
8%
Poorly correlated
+2.77%
STEK - HLBBF
2%
Poorly correlated
+0.55%
More